Drug Profile

CM 5480

Alternative Names: CM-5480

Latest Information Update: 28 Aug 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator CalciMedica
Class Anti-infectives; Small molecules
Mechanism of Action Calcium channel antagonists; Immunosuppressants; ORAI1 protein inhibitors; STIM1 protein inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

No development reported Pancreatitis

Most Recent Events

28 Aug 2024 No recent reports of development identified for preclinical development in Pancreatitis in USA (Parenteral)
06 Jun 2023 Pharmacodynamics data from a preclinical trial in pancreatitis released by CalciMedica
21 Jul 2020 CalciMedica and Epipharma enters research collaboration for development of CM 5480

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com